False-negative rates for MYC fluorescence in situ hybridization probes in B-cell neoplasms

• Rebecca L. King,
• Ellen D. McPhail,
• Reid G. Meyer,
• George Vasmatzis,
• Kathryn Pearce,
• James B. Smadbeck,
• Rhett P. Ketterling,
• Stephanie A. Smoley,
• Patricia T. Greipp,
• Nicole L. Hoppman,
• Jess F. Peterson,
• Linda B. Baughn

Affiliations

Rebecca L. King

Division of Hematopathology, Department of Laboratory Medicine and Pathology

Ellen D. McPhail

Division of Hematopathology, Department of Laboratory Medicine and Pathology

Reid G. Meyer

Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology

George Vasmatzis

Center for Individualized Medicine-Biomarker Discovery, Mayo Clinic, Rochester, MN, USA

Kathryn Pearce

Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology

James B. Smadbeck

Center for Individualized Medicine-Biomarker Discovery, Mayo Clinic, Rochester, MN, USA

Rhett P. Ketterling

Division of Hematopathology, Department of Laboratory Medicine and Pathology;Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology

Stephanie A. Smoley

Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology

Patricia T. Greipp

Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology

Nicole L. Hoppman

Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology

Jess F. Peterson

Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology

Linda B. Baughn

Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology